-
Top News: Cablevision Systems Corporation (NYSE:CVC), Sage Therapeutics (NASDAQ:SAGE), Infinera Corporation (NASDAQ:INFN), Littelfuse Inc. (NASDAQ:LFUS), PRGX Global (NASDAQ:PRGX)
On Wednesday shares of Cablevision Systems Corporation (NYSE:CVC) closed at $20.80. Company’s sales growth for last 5 years was 2.10% and EPS growth for next 5 years is recorded as -1.75%. Cablevision Systems Corp. (NYSE:CVC) on 4 May, reported first-quarter net income of $44.6 million. On a per-share basis, the Bethpage, New York-based company said…
-
Investors Alert: Cablevision Systems Corporation (NYSE:CVC), Pacific Biosciences of California (NASDAQ:PACB), CTC Media, Inc (NASDAQ:CTCM), Arena Pharmaceuticals (NASDAQ:ARNA), Baidu (NASDAQ:BIDU)
On Friday shares of Cablevision Systems Corporation (NYSE:CVC) closed at $20.15. Company’s sales growth for last 5 years was 2.10% and EPS growth for next 5 years is recorded as -1.05%. Cablevision Systems Corporation (NYSE:CVC) has unveiled a new internet-focused Optimum product targeting the ‘cord cutter’ and ‘cord never’ generation of consumers. Pacific Biosciences of…
-
Top News: Intercept Pharmaceuticals (NASDAQ:ICPT), IRIDEX Corporation (NASDAQ:IRIX), Scripps Networks Interactive (NYSE:SNI), Himax Technologies (NASDAQ:HIMX), Cablevision Systems Corporation (NYSE:CVC)
On Thursday shares of Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) closed at $274.44. Company’s EPS growth for next 5 years is recorded as 18.01%. On 6 April, Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) announced the completion of its previously announced underwritten public offering of 1,200,000 shares of its common stock. In addition, Intercept announced the completion of the sale…
-
Don’t Miss: Oncolytics Biotech Inc. (NASDAQ:ONCY), DGSE Companies Inc. (NYSEMKT:DGSE), AXIS Capital Holdings Limited (NYSE:AXS), Cablevision Systems Corporation (NYSE:CVC), Vista Gold (NYSEMKT:VGZ)
On Thursday shares of Oncolytics Biotech Inc. (NASDAQ:ONCY) closed at $0.77. Oncolytics Biotech Inc. (NASDAQ:ONCY)’s lead pipeline candidate, Reolysin, has been granted orphan drug status by the EMA for the treatment of ovarian, fallopian tube and primary peritoneal cancers. The company is also seeking orphan drug status for the candidate for the treatment of pancreatic…
-
Fast Moving Stocks: CymaBay Therapeutics Inc. (NASDAQ:CBAY), Pfizer Inc. (NYSE:PFE), Cabot Microelectronics Corporation (NASDAQ:CCMP), Cablevision Systems Corporation (NYSE:CVC), BlackBerry Ltd (NASDAQ:BBRY)
On Thursday shares of CymaBay Therapeutics Inc. (NASDAQ:CBAY) closed at $9.01. CymaBay Therapeutics Inc. (NASDAQ:CBAY) on Wednesday reported a fourth-quarter loss of $12.7 million, after reporting a profit in the same period a year earlier. On a per-share basis, the Newark, California-based company said it had a loss of 87 cents. For the year, the…
-
Notable Stocks in Focus: Sirius XM Holdings Inc. (NASDAQ:SIRI), Selectica (NASDAQ:SLTC), Smith & Nephew (NYSE:SNN), Delta Apparel (NYSEMKT:DLA), Cablevision Systems (NYSE:CVC)
A unit of Sirius XM Holdings Inc. (NASDAQ:SIRI) plans to sell $750 million in senior notes to pay down debt and to back share repurchases of the company’s common stock, among other corporate purposes, the satellite radio broadcasting giant said on 3 march. On Thursday shares of Sirius XM Holdings Inc. (NASDAQ:SIRI) closed at $3.92.…
-
Stock Alert: Infinity Pharmaceuticals (NASDAQ:INFI), Cablevision Systems Corporation (NYSE:CVC), Micrel Inc. (NASDAQ:MCRL), G&K Services Inc. (NASDAQ:GK), Penn Virginia Corporation (NYSE:PVA)
Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) announced Net loss for full-year 2014 was $17.4 million, or a basic and diluted loss per common share of $0.36, compared to $126.8 million, or a basic and diluted loss per common share of $2.64 for 2013.On Wednesday shares of Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) closed at $15.12. Company’s EPS growth for…
-
Stock in News: EPIRUS Biopharmaceuticals (NASDAQ:EPRS), SodaStream International (NASDAQ:SODA), Cablevision Systems Corporation (NYSE:CVC), MannKind Corp. (NASDAQ:MNKD), Ballard Power Systems (NASDAQ:BLDP)
Wedbush assumed coverage on shares of Epirus Biopharmaceuticals (NASDAQ:EPRS) in a report released on Wednesday, TheFlyOnTheWall.com reports. The firm issued a buy rating and a $13.00 price objective on the stock. On Wednesday shares of EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) closed at $10.36. Company’s sales growth for last 5 years was 3.60%. SodaStream International Ltd. (NASDAQ:…
-
Market Watch: Cablevision Systems Corporation (NYSE:CVC), RiceBran Technologies (NASDAQ:RIBT), Health Care REIT (NYSE:HCN), Pandora Media Inc (NYSE:P), NCI (NASDAQ:NCIT)
Cablevision Systems Corporation (NYSE:CVC) on Wednesday reported fourth-quarter net income of $56 million. On a per-share basis, the Bethpage, New York-based company said it had profit of 20 cents. The results exceeded Wall Street expectations. The average estimate of analysts surveyed by Zacks Investment Research was for earnings of 19 cents per share. The cable…
-
Trader’s Buzz: Halliburton Company (NYSE:HAL), Kite Pharma (NASDAQ:KITE), Monster Beverage Corporation (NASDAQ:MNST), Cablevision Systems Corporation (NYSE:CVC), Stamps.com Inc. (NASDAQ:STMP)
Halliburton Company (NYSE:HAL) is still refusing to say how many jobs are on the line in Aberdeen – or any other location in operations in more than 80 countries. The job reduction move was announced earlier this month but only in worldwide percentage terms. The firm will give no more details about the redundancies, which…